Finance
Markets
No recent trading data. The last price we hold for LH is from Jun 3 (48 days ago). This symbol may be delisted, renamed, or halted — the figures below reflect its last active session, not the current market.

LH

stock Healthcare Diagnostics & Research
Labcorp
$258.92 +1.22 (+0.47%) Delayed · quoted 47d ago
Mixed 54% Climbing

What the indicators say

Mixed 1 of 5 trend signals bullish
Momentum · RSI 14 Neutral
50
0oversold 30overbought 70100

RSI 50 — momentum is balanced between buyers and sellers.

EMA 21 $258.38
Above
Near-term trend is up
SMA 50 $262.27
Below
Medium-term trend is down
SMA 200 $268.16
Below
Long-term trend is down
50 / 200-day
Death cross
50-day below the 200-day — bearish
Supertrend $270.49
Downtrend
Price is below the Supertrend band — bearish

A mechanical reading of the chart’s indicators — not investment advice.

Key statsas of Jun 3

The day open and close within the day's range
Low $253.06 High $259.58
Open
$258.92
+0.47%
Close
$258.92
+0.47%
52-week range where the price sits across its year
52w low $241.81 52w high $293.72
Current
$258.92
Prev close
$257.70
Volume 0.8× the 3-month average
0 avg 2× avg
Today
490.19K
3-mo avg
610.70K

Earningscalendar synced from Yahoo 57d ago

Most recent
Apr 3082 days ago
Next expected
Jul 23in 2 days

Recent earnings dates

  • Apr 30 82 days ago
  • Feb 17 154 days ago
  • Oct 28, 2025 266 days ago
  • Jul 24, 2025 362 days ago

Past earnings dates come from LH’s 8-K item 2.02 filings; the next date is Yahoo’s when available, otherwise estimated from the recent reporting cadence.

Fundamentalssynced from SEC 51d ago

Strong

Across the nine graded ratios (FY2025 balance-sheet figures, P/E on TTM through Mar 2026 earnings, against the latest price), LH’s fundamentals read as strong overall.

P/E ratio Strong
22.9x

At 22.9x, the price is a reasonable multiple of the company's annual profit.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
1.11%

A 1.1% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Fair
6.3%

A 6.3% margin is solid, in the ordinary range for a profitable company.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
10.2%

A 10.2% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
4.8%

A 4.8% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity Fair
1.13

At 1.13, the company carries a moderate, manageable amount of debt.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Fair
1.42

At 1.42, short-term assets cover short-term bills with a little room to spare.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+7.2%

Revenue grew 7.2% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Strong
+17.5%

Net income grew 17.5% from the prior year: strong profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financialssynced from SEC 51d ago

FY2021FY2022FY2023FY2024FY2025
Revenue $13.1B$11.9B$12.2B$13.0B$14.0B
Net income $2.4B$1.3B$418.0M$746.0M$876.5M
Diluted EPS $24.39$13.97$4.77$8.84$10.46
Dividend / share $2.16$2.88$2.88$2.88
Total assets $20.4B$20.2B$16.7B$18.4B$18.4B
Total liabilities $10.1B$10.0B$8.8B$10.3B$9.8B
Shareholder equity $10.3B$10.1B$7.9B$8.1B$8.6B

Leadershipsynced from SEC 55d ago

  • Schechter Adam H President & CEO · Director
  • Schroeder Mark S EVP, Pres Diagnostics & COO
  • Caveney Brian J EVP, Pres of ED, CMO & CSO
  • Graham Anita Z EVP, CHRO
  • Oyegunwa Akinbolade EVP, CIO & CTO
  • Summy Amy B. EVP, Chief Marketing Officer
  • Van Der Vaart Sandra D EVP, Corporate Affairs
  • Vaughn Bryan T EVP, Diagnostics
  • Wilkinson Peter J SVP, Chief Accounting Officer

Officers and board are drawn from LH’s recent SEC ownership filings (Forms 3, 4 and 5).

Notable recent eventspast year

Large daily moves, new 6-month lows, year-over-year fundamentals swings, and reported leadership changes — pulled from the data this app already holds, never investment advice.

Dividendssynced from Yahoo 52d ago

Pays quarterly Fair
2025 total
$2.88
2026 so far
$1.442 payments
2026 projected
$2.88+0.0% vs 2025

Projection scales LH’s declared payments so far this year up to the inferred cadence, then compares to last year’s total. Between payouts it is an estimate, not a guarantee.

Payment history

  • May 29 $0.72
  • Feb 27 $0.72
  • Nov 26, 2025 $0.72
  • Aug 28, 2025 $0.72
  • May 29, 2025 $0.72
  • Feb 27, 2025 $0.72
  • Nov 26, 2024 $0.72
  • Aug 29, 2024 $0.72
  • May 24, 2024 $0.72
  • Feb 26, 2024 $0.72
  • Nov 7, 2023 $0.72
  • Aug 7, 2023 $0.72
  • May 17, 2023 $0.62
  • Feb 22, 2023 $0.62
  • Nov 16, 2022 $0.62
  • Aug 17, 2022 $0.62
  • May 18, 2022 $0.62

Recent SEC filingssynced from SEC 51d ago